Big Pharma Is Synthesizing Cannabis To Make A Patent-able Pill. @ravboc, @dr_rahul_mishra usahealthtimes.com/2018/05/13/big… via USA Health Times

Patents for Combination Products: Challenges and Opportunities – DrugPatentWatch - Make Better Decisions. @ravboc; @dr_rahul_mishra drugpatentwatch.com/blog/patents-c…

#PLOSONE: Indian pharmaceutical patent prosecution: The changing role of Section 3(d) @ravboc, @dr_rahul_mishra dx.plos.org/10.1371/journa…

China claims more patents than any country—most are worthless. @ravboc, dr-rahul_mishra bloomberg.com/news/articles/… via Bloomberg Technology

Better therapies are desperately needed for Sickle Cell Disease (SCD). @ravboc, @dr_rahul_mishra The FDA Encourages New Treatments for Sickle Cell Disease fda.gov/ForConsumers/C…

Artificial intelligence (AI): A detailed report from WIPO. Includes projections and latest trends in AI based on the analysis of patents and scientific publications. @ravboc CSIR-CEERI CSIR-CSIO CSIR-NGRI Offl. A/c @Dr_Rahul_Mishra wipo.int/tech_trends/en… wipo.int/edocs/pubdocs/…

Indirectly targeting the oncogene MYC by blocking the protein ATF4 may offer a new strategy for treating several cancers. @ravboc, @Dr_Rahul_Mishra, @IGIB_DEL_110007, CCMB, CSIR-CDRI fiercebiotech.com/research/penn-…

This will help in increasing the reliability and predictability of future AI patents in the US and for other countries to learn from. @ravboc, @Dr_Rahul_Mishra, The Real Reason Why America Is Inviting Public Comments On AI Patents analyticsindiamag.com/the-real-reaso… via AIM